Bevacizumab and Nimustine in Patients With Recurrent High Grade Glioma

NCT02698280 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Bevacizumab
DRUG: Nimustine

Sponsor

Huashan Hospital